Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value
-
Shares outstanding
-
9,614,000
-
Total 13F shares
-
21,887,052
-
Share change
-
-1,888,430
-
Total reported value
-
$64,565,221
-
Put/Call ratio
-
12%
-
Price per share
-
$2.95
-
Number of holders
-
75
-
Value change
-
-$5,342,980
-
Number of buys
-
30
-
Number of sells
-
51
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2023
As of 30 Jun 2023,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,887,052 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, BML Capital Management, LLC, VANGUARD GROUP INC, Simplify Asset Management Inc., Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BANK OF AMERICA CORP /DE/, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.